2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-methoxy-4-methyl-6,8-dioxo-, (4R,12aR)-
|
多替拉韋/巴洛沙韋雜質(zhì)D32-001
|
2384108-28-3
|
1-Propanamine, N-methyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-
|
芐達(dá)明雜質(zhì)B18-001
|
32852-16-7
|
2-[3-(Dimethylamino)propyl]-1,2-dihydro-1-(phenylmethyl)-3H-indazol-3-one
|
芐達(dá)明雜質(zhì)B18-002
|
52413-42-0
|
1,3-Propanediamine, N1,N1,N3-trimethyl-N3-[3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]propyl]-
|
芐達(dá)明雜質(zhì)B18-003
|
1337966-15-0
|
NA
|
哌柏西利雜質(zhì)P03-003
|
362658-21-7
|
INDEX NAME NOT YET ASSIGNED
|
哌柏西利雜質(zhì)P03-011
|
2399424-46-3
|
6-acetyl-2-aMino-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one
|
哌柏西利雜質(zhì)P03-020
|
571189-64-5
|
1,3-Dioxol-2-one, 4,5-bis(hydroxymethyl)-
|
美阿沙坦鉀雜質(zhì)M02-002
|
1417576-03-4
|
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-
|
美阿沙坦鉀雜質(zhì)M02-003
|
1234834-29-7
|
4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-6-phenyl-, 5-oxide
|
艾司唑侖雜質(zhì)A18-001
|
29975-18-6
|
N'-[[(2-benzoyl-4-chlorophenyl)(chloroacetyl)amino]methylene]chloroacetohydrazide
|
艾司唑侖雜質(zhì)A18-002
|
49691-65-8
|
2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-phenyl-, hydrazone, (Z)- (9CI)
|
艾司唑侖雜質(zhì)A18-003
|
112393-62-1
|
(5aR,10aR)-1,2,3,5a,6,7,8,10a-octahydrodipyrrolo[1,2-c:1',2'-f]pyrazine-5,10-dione
|
L-脯氨酸雜質(zhì)P16-002
|
53990-71-9
|
2-Hexenoic acid, 4,5-dihydroxy-, (2E,4S,5R)-
|
左卡尼汀雜質(zhì)Z01-001
|
931426-06-1
|
2-Hexenoic acid, 4,5-dihydroxy-
|
左卡尼汀雜質(zhì)Z01-002
|
873385-02-5
|
(11β,17Z)-11,20-Dihydroxy-3-oxo-pregna-4,17(20)-dien-21-al
|
氫化可的松雜質(zhì)Q02-001
|
105562-13-8
|
(11β,17E)-11,20-dihydroxy-3-oxo-pregna-4,17(20)-dien-21-al
|
氫化可的松雜質(zhì)Q02-002
|
105562-12-7
|
Propanoic acid, 2-[[(Z)-[1-(2-amino-4-thiazolyl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methyl-, 1-(1,1-dimethylethyl) ester
|
氨曲南雜質(zhì)A25-004
|
330944-50-8
|
Carbidopa Methyl Ester
|
卡比多巴雜質(zhì)K02-001
|
91431-01-5
|
Carbidopa Ethyl Ester
|
卡比多巴雜質(zhì)K02-002
|
91908-71-3
|
riboflavin 3',5'-bisphosphate
|
核黃素雜質(zhì)H01-001
|
86108-26-1
|
Riboflavin 4’,5’-Diphosphate
|
核黃素雜質(zhì)H01-002
|
86108-25-0
|
1487411-82-4
|
阿昔替尼雜質(zhì)A13-001
|
1487411-82-4
|
Butanoic acid, 2-[(4-cyano-2-methoxyphenyl)methylene]-3-oxo-, ethyl ester
|
非奈利酮雜質(zhì)F06-003
|
959934-80-6
|
Finerenone impurity 34
|
非奈利酮雜質(zhì)F06-005
|
2924224-42-8
|
2-Cyanoethyl (2E)-2-[(4-cyano-2-methoxyphenyl)methylene]-3-oxobutanoate
|
非奈利酮雜質(zhì)F06-012
|
1870824-79-5
|
Bedaquiline Impurity 5
|
貝達(dá)喹啉雜質(zhì)B06-001
|
916801-19-9
|
2-amino-4-ethyl-5-methylbenzene-1,3-dicarbonitrile
|
奧氮平雜質(zhì)A33-009
|
55525-92-3
|
N-Formyl-5-asa
|
氨氯地平雜質(zhì)A24-023
|
104786-99-4
|
Ethyl diazophenylacetate
|
格隆溴銨雜質(zhì)G05-011
|
22065-57-2
|
Propanamide, 2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]hydroxyamino]-, (2S)-
|
沙芬酰胺雜質(zhì)S03-006
|
2270245-27-5
|
Mirabegron Impurity Q
|
米拉貝隆雜質(zhì)M09-002
|
1684452-92-3
|
1-Piperazinecarbonyl chloride (9CI)
|
佐匹克隆雜質(zhì)Z04-001
|
69433-07-4
|
Benzoic acid, 4-hydroxy-, 4-carboxyphenyl ester
|
丙泊酚雜質(zhì)B21-001
|
40677-31-4
|
Pentanedioic acid, 3-(3-furanyl)-
|
納呋拉啡雜質(zhì)N01-001
|
2228413-62-3
|
DICHLORO-N-METHYLACETAMIDE
|
他達(dá)那非雜質(zhì)T01-001
|
5345-73-3
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]-2-propoxyphenyl]-5-methyl-7-propyl-
|
伐地那非雜質(zhì)F01-001
|
1339092-18-0
|
Benzenepropanamine, N-hydroxy-N-methyl-γ-[4-(trifluoromethyl)phenoxy]-
|
氟西汀雜質(zhì)F13-001
|
1624625-05-3
|
Hydrazine amide of deoxycholic acid
|
去氧膽酸雜質(zhì)Q13-001
|
96840-44-7
|
DL-METHIONINE-D3
|
蛋氨酸雜質(zhì)D06-002
|
284665-20-9
|
2H-Pyrrole-2-carboxylicacid,5-amino-3,4-dihydro-,(S)-(9CI)
|
呱侖酸鈉雜質(zhì)G06-001
|
111631-17-5
|
sodium dihydrogen 2-sulphonatosuccinate
|
琥珀酸鈉雜質(zhì)H02-001
|
29454-16-8
|
estradiol 17-sulfate
|
雌二醇雜質(zhì)C02-001
|
3233-69-0
|
(R)-4,5-Dehydro Pregabalin
|
普瑞巴林雜質(zhì)P15-001
|
1101167-84-3
|
2(1H)-Pyridinone, 1-(2-chlorophenyl)-5-methyl-
|
吡非尼酮雜質(zhì)B14-001
|
1198414-06-0
|
2(1H)-Pyrimidinone,4-amino-1-b-D-arabinofuranosyl-, 3-oxide
|
阿糖胞苷雜質(zhì)A09-001
|
30902-36-4
|
Cytarabine Impurity 10
|
阿糖胞苷雜質(zhì)A09-002
|
84902-98-7
|
1,3,5-Triazine-2,4-diamine, 3,6-dihydro-N2,N2,6-trimethyl-, hydrochloride (1:1)
|
依格列明雜質(zhì)Y07-001
|
352211-11-1
|
7H,14H-Pyrazino[1,2-b:4,5-b]diindazole-7,14-dione
|
格拉司瓊雜質(zhì)G04-001
|
115660-68-9
|
Metronidazole Impurity 3
|
甲硝唑雜質(zhì)J06-007
|
5006-79-1
|
Benzamide, 3-amino-4-(methylamino)-N-[3-oxo-3-(2-pyridinylamino)propyl]-N-2-pyridinyl-
|
達(dá)比加群酯雜質(zhì)D01-007
|
2931469-64-4
|
N-(4-cyanophenyl)-2-((4-cyanophenyl)amino)acetamide
|
達(dá)比加群酯雜質(zhì)D01-008
|
1900865-84-0
|
Dabigatran impurity 73
|
達(dá)比加群酯雜質(zhì)D01-010
|
858967-80-3
|
3-[(4-chloro-3-nitrobenzoyl)pyridin-2-yl-amino]propionic acid ethyl ester
|
達(dá)比加群酯雜質(zhì)D01-012
|
1620205-04-0
|
Bedaquiline Impurity 13
|
貝達(dá)喹啉雜質(zhì)B06-002
|
2122862-01-3
|
(5alpha)-4,5-Epoxy-3,14-dihydroxy-6-oxomorphinan-17-carboxaldehyde
|
納美芬雜質(zhì)N02-001
|
1007856-83-8
|
Nalmefene Impurity
|
納美芬雜質(zhì)N02-002
|
738552-29-9
|
Naltrexone EP Impurity H
|
納美芬雜質(zhì)N02-003
|
503090-99-1
|
Impurity
|
坎地沙坦酯雜質(zhì)K05-001
|
1821385-89-0
|
2-Ethoxy-1-(tetrazolo[1,5-f]phenanthridin-6-ylmethyl)-1H-benzimidazole-7-carboxylic acid
|
坎地沙坦酯雜質(zhì)K05-002
|
1821386-35-9
|
2-Cyclohexen-1-one, 5-(4-chlorophenyl)-3-methyl-
|
巴氯芬雜質(zhì)B02-007
|
54795-01-6
|
2-(Sodiooxy)-1-cyclopentene-1-carboxylic acid methyl ester
|
洛索洛芬雜質(zhì)L19-001
|
63178-03-0
|
Brimonidine Impurity 14
|
溴莫尼定雜質(zhì)X10-006
|
934548-66-0
|
4-((2-amino-2-oxoethyl)amino)butanoic acid
|
吡拉西坦雜質(zhì)B16-001
|
1096803-44-9
|
3-Furancarbonitrile, 2-amino-5-(2-fluorophenyl)-
|
沃諾拉贊/伏諾拉生雜質(zhì)W01-001
|
312307-69-0
|
Isoquinolinium, 2-[3-[[(4E)-7-carboxy-1-oxo-4-hepten-1-yl]oxy]propyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-, chloride (1:1), (1R,2S)-
|
米庫氯銨雜質(zhì)M08-006
|
161816-38-2
|
Lomefloxacin Impurity 3
|
洛美沙星雜質(zhì)L18-007
|
183235-15-6
|
1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid ethyl ester
|
洛美沙星雜質(zhì)L18-008
|
98079-83-5
|
2-Imidazolidinecarboxamide, N-(2,6-dimethylphenyl)-4-methyl-1-(2-methylphenyl)-5-oxo-3-propyl-
|
丙胺卡因雜質(zhì)B19-014
|
2509057-86-5
|
Ketoprofen Impurity 15
|
酮洛芬雜質(zhì)T07-010
|
1257296-76-6
|
2,4-Furandiol, tetrahydro-2-(hydroxymethyl)-
|
乳果糖雜質(zhì)R01-001
|
136272-61-2
|
Dobutamine Impurity 6
|
多巴酚丁胺雜質(zhì)D27-005
|
140165-60-2
|
NA
|
多巴酚丁胺雜質(zhì)D27-006
|
|
NA
|
多巴酚丁胺雜質(zhì)D27-007
|
|
4-METHYL-3-[[1-OXO-2-(PROPYLAMINO)PROPYL]AMINO]-2-THIOPHENECARBOXYLIC ACID
|
阿替卡因雜質(zhì)A10-011
|
114176-52-2
|
Lomefloxacin Impurity
|
洛美沙星雜質(zhì)L18-009
|
111234-01-6
|
Lomefloxacin Impurity 8
|
洛美沙星雜質(zhì)L18-010
|
195259-19-9
|
Lomefloxacin Impurity
|
洛美沙星雜質(zhì)L18-012
|
195259-11-1
|
Dabigatran Impurity i
|
達(dá)比加群酯雜質(zhì)D01-013
|
1354892-78-6
|
1H-Pyrrole-2,5-dione, 3,4-bis(hydroxymethyl)-
|
維生素B6雜質(zhì)W03-001
|
2775363-46-5
|
3,4-Pyridinedimethanol,5-hydroxy-6-methyl-, 1-oxide
|
維生素B6雜質(zhì)W03-002
|
16567-04-7
|
Pyridoxine Impurity 9
|
維生素B6雜質(zhì)W03-003
|
1385767-86-1
|
Pyridoxine Impurity 5
|
維生素B6雜質(zhì)W03-004
|
412940-03-5
|
Benzoic acid, 3-[[[(2S,4S)-4-hydroxy-2-pyrrolidinyl]carbonyl]amino]-
|
厄他培南雜質(zhì)E01-001
|
266337-30-8
|
Benzoic acid, 3-[[[(2S,4R)-4-hydroxy-2-pyrrolidinyl]carbonyl]amino]- (9CI)
|
厄他培南雜質(zhì)E01-002
|
770703-11-2
|
3-Thiophenecarboxylic acid, 4-formyl-2,5-dihydro-2-(4-hydroxybutylidene)-5-methyl-, (2Z)-
|
法羅培南雜質(zhì)F02-001
|
1025974-23-5
|
Hydrazinecarboxamide, 1-[(1S,2S)-1-ethyl-2-(phenylmethoxy)propyl]-2-formyl-N-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-
|
泊沙康唑雜質(zhì)P11-003
|
2889357-64-4
|
161532-54-3
|
泊沙康唑雜質(zhì)P11-005
|
161532-54-3
|
4-(4-{4-[(3R,5R)-5-(2,4-DIFLUORO-PHENYL)-5-[1,2,4]TRIAZOL-1-YLMETHYL-TETRAHYDRO-FURAN-3-YLMETHOXY]-PHENYL}-PIPERAZIN-1-YL)-PHENYLAMINE
|
泊沙康唑雜質(zhì)P11-006
|
184378-04-9
|
LROQBKNDGTWXET-FVWDGWMTSA-N
|
加蘭他敏雜質(zhì)J03-004
|
199014-26-1
|
3-(2-Amino-1-chloropropyl)phenol
|
間羥胺雜質(zhì)J11-003
|
1379208-51-1
|
NQT Impurity E
|
納曲酮雜質(zhì)N03-002
|
767615-69-0
|
Naltrexone 3-Methyl Ether
|
納曲酮雜質(zhì)N03-003
|
16617-07-5
|
Naltrexone EP Impurity C
|
納曲酮雜質(zhì)N03-004
|
189016-90-8
|
5-Benzamido-4-oxopentanoic acid
|
氨酮戊酸雜質(zhì)A26-002
|
102872-00-4
|
6-Hydroxy-2-naphthamide
|
萘莫司他雜質(zhì)N06-001
|
62529-01-5
|
2,5-Pyridinedicarboxylic acid, 1-(2,2-dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-
|
多替拉韋雜質(zhì)D31-003
|
2651309-06-5
|
Ibrutinib Impurity 14
|
伊布替尼雜質(zhì)Y02-001
|
2417548-76-4
|
1,3-Benzodioxole, 5,5'-methylenebis-
|
吡貝地爾雜質(zhì)B13-011
|
4971-68-0
|
2H-Pyrido[1,2-a]pyrazine-7-carboxylic acid, 1,8-dihydro-2-[(1R)-3-hydroxy-1-methylpropyl]-9-methoxy-1,8-dioxo-
|
多替拉韋雜質(zhì)D31-002
|
2710626-41-6
|